EICHORPublic-registry site landscape for NCT04968912, “A Study of Nipocalimab in Adults With Primary Sjogren's Syndrome (pSS)”, a Sjogren's Syndrome study sponsored by Janssen Research & Development, LLC. All data below is from public sources; Eichor is not affiliated with the sponsor.
| Trial | NCT04968912 (registry record) |
| Study title | A Study of Nipocalimab in Adults With Primary Sjogren's Syndrome (pSS) |
| Official title | A Randomized, Placebo-controlled, Double-blind, Multicenter Study to Assess the Efficacy and Safety of Nipocalimab in Adults With Primary Sjogren's Syndrome (pSS) |
| Sponsor | Janssen Research & Development, LLC |
| Condition(s) | Sjogren's Syndrome |
| Phase | PHASE2 |
| Listed sites | 69 |
| Site countries | United States, France, Germany, Italy, Japan, Netherlands, Poland, Portugal, Spain, Taiwan |
Patient-friendly overview of this study: eichor.com/study/NCT04968912.
Eichor generates a preliminary site-risk snapshot for NCT04968912 — how the roster screens on competing-trial load, enrollment track record, and PI–indication fit — free, usually same day. Request it here →
More from Janssen Research & Development, LLC
← Eichor home · All tracked trials · Sjogren's Syndrome studies · Weekly briefs
